Best Doctors for Hormone therapy in Germany

Prof. Dr. med. Ahmet Elmaagacli

Medical Oncologist

Hamburg, Germany

42+ years of experience

Chief

Works At: Asklepios Hospital Barmbek, Hamburg

5.0 (12 Ratings)

WhatsApp Us

Prof. Dr. med. Ahmet Elmaagacli is a haemato-oncologist with 32+ years of experience.
His areas of expertise include subarachnoid hematoma (SAH) treatment, pediatric oncology and hematology- oncology.
He has been awarded the title of 'Extraordinary Professor' at the University of Duisburg-Essen, 2007, "BALANCE AWARD 2007" for the research project and “JIAN-JIAN LUAN” AWARD of the European Group for Blood and Marrow Transplantation for best contribution to lymphoma transplant research 2012.
Dr. Elmaagacli is a member of the Association of German Internists, European Bone Marrow Transplantation Group, American Association of Hematology (ASH), German Society for Hematology and Oncology (DGHO) and Turkish Society of Hematology.
He completed graduation followed by post-graduation and Ph.D. from the prestigious university in Germany.
He has many publications under his name in both national and international journals.

Prof. Dr. med. Ahmet Elmaagacli is a haemato-oncologist with 32+ years of experience.
His areas of expertise include subarachnoid hematoma (SAH) treatment, pediatric oncology and hematology- oncology.
He has been awarded the title of 'Extraordinary Professor' at the University of Duisburg-Essen, 2007, "BALANCE AWARD 2007" for the research project and “JIAN-JIAN LUAN” AWARD of the European Group for Blood and Marrow Transplantation for best contribution to lymphoma transplant research 2012.
Dr. Elmaagacli is a member of the Association of German Internists, European Bone Marrow Transplantation Group, American Association of Hematology (ASH), German Society for Hematology and Oncology (DGHO) and Turkish Society of Hematology.
He completed graduation followed by post-graduation and Ph.D. from the prestigious university in Germany.
He has many publications under his name in both national and international journals.

Prof. Dr. Marion Kiechle

Medical Oncologist

Munich, Germany

31+ years of experience

Director

Works At: University Hospital Rechts der Isar

WhatsApp Us

Prof. Dr. Marion Kiechle is an Internationally renowned Medical Oncologist with +30 years of practice.
Her area of expertise is Breast cancer, Gynecological cancer and the diagnosis, treatment and prevention of Tumor disease in women.
She is a member of the German Medical Association, the German Society of Gerontology and Geriatrics and the German Cancer Society.
Prof. Dr. Marion Kiechle gained her MBBS (1986) from the University of Freiburg.
She did her specialization in Oncology (1987) at the University of Freiburg.
She has a PhD (1995) from the University Hospital Freiburg.
Prof. Dr. Marion Kiechle is the author of several publications and articles.

Prof. Dr. Marion Kiechle is an Internationally renowned Medical Oncologist with +30 years of practice.
Her area of expertise is Breast cancer, Gynecological cancer and the diagnosis, treatment and prevention of Tumor disease in women.
She is a member of the German Medical Association, the German Society of Gerontology and Geriatrics and the German Cancer Society.
Prof. Dr. Marion Kiechle gained her MBBS (1986) from the University of Freiburg.
She did her specialization in Oncology (1987) at the University of Freiburg.
She has a PhD (1995) from the University Hospital Freiburg.
Prof. Dr. Marion Kiechle is the author of several publications and articles.

Dr. med. Axel Stang

Medical Oncologist

Hamburg, Germany

43+ years of experience

Director

Works At: Asklepios Hospital Barmbek, Hamburg

WhatsApp Us

Dr. med. Axel Stang is a hematologist and oncologist with 39+ years of experience.
He won the Asklepios Award for Innovation in Medicine in 2012.
He is a member of the Hamburg Medical Association
He has given guest lectures at the Semmelweis University Budapest.
Dr. Stang completed graduation followed by post-graduation and PhD.
He also did basic ultrasound courses and has ESMO Certification in medical oncology.
He is a member of the German Cancer Society (AIO), German Society for Hematology and Oncology (DGHO), German Society for Internal Medicine (DGIM), German Society for Palliative Medicine, German Society for Ultrasound in Medicine (DEGUM) and European Society of Medical Oncology (ESMO).

Dr. med. Axel Stang is a hematologist and oncologist with 39+ years of experience.
He won the Asklepios Award for Innovation in Medicine in 2012.
He is a member of the Hamburg Medical Association
He has given guest lectures at the Semmelweis University Budapest.
Dr. Stang completed graduation followed by post-graduation and PhD.
He also did basic ultrasound courses and has ESMO Certification in medical oncology.
He is a member of the German Cancer Society (AIO), German Society for Hematology and Oncology (DGHO), German Society for Internal Medicine (DGIM), German Society for Palliative Medicine, German Society for Ultrasound in Medicine (DEGUM) and European Society of Medical Oncology (ESMO).

Pd Dr. Med Peter Reichardt

Medical Oncologist

Berlin, Germany

39+ years of experience

Chief

Works At: Helios Hospital, Berlin

WhatsApp Us

Pd Dr. Med Peter Reichardt is a medical oncologist with 35+ years of experience.
His areas of expertise include soft tissue sarcomas, bone tumors, gastrointestinal stromal tumors, malignant skin tumors, oesophageal carcinomas, gastric carcinomas, pancreatic carcinomas, neuroendocrine tumors, gall bladder and bile duct carcinomas.
He is a member of the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), Connective Tissue Oncology Society (CTOS), German Oncology Society, German Oncology Society (AIO), German Society for Hematology and Medical Oncology (DGHO), European Organization for Research and Treatment of Cancer (EORTC) and Sarcoma Foundation of America.
Dr. Reichardt completed his graduation from Heidelberg University, Heidelberg followed by PhD.
He has presented more 900 talks at national and international scientific conferences.
He has more than 130 scientific papers in the field of specialization.

Pd Dr. Med Peter Reichardt is a medical oncologist with 35+ years of experience.
His areas of expertise include soft tissue sarcomas, bone tumors, gastrointestinal stromal tumors, malignant skin tumors, oesophageal carcinomas, gastric carcinomas, pancreatic carcinomas, neuroendocrine tumors, gall bladder and bile duct carcinomas.
He is a member of the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), Connective Tissue Oncology Society (CTOS), German Oncology Society, German Oncology Society (AIO), German Society for Hematology and Medical Oncology (DGHO), European Organization for Research and Treatment of Cancer (EORTC) and Sarcoma Foundation of America.
Dr. Reichardt completed his graduation from Heidelberg University, Heidelberg followed by PhD.
He has presented more 900 talks at national and international scientific conferences.
He has more than 130 scientific papers in the field of specialization.

Get FREE Evaluation

Treatment plan and quote within 2 days

Dr. Mark Schrader

Medical Oncologist

Berlin, Germany

29+ years of experience

Chief

Works At: Helios Hospital, Berlin

5.0 (12 Ratings)

WhatsApp Us

Dr. Mark Schrader is an oncologist and urologist with 25+ years of experience.
His areas of expertise include gallbladder cancer, prostate cancer, benign prostatic hyperplasia (BPH), kidney cancer, testicular cancer, prostatic hyperplasia and benign testicular tumor.
He is a member of the Berlin Medical Association, European Association of Urology, Urologic Oncology Association and German Society of Ultrasound in Medicine and Biology.
Dr. Schrader completed his graduation from Johannes Gutenberg University Mainz, Germany and post-graduation from Charité - Universitätsmedizin Berlin, Germany.
He has presented more than 120 research papers.
He has many publications under his name in journals of international repute.

Dr. Mark Schrader is an oncologist and urologist with 25+ years of experience.
His areas of expertise include gallbladder cancer, prostate cancer, benign prostatic hyperplasia (BPH), kidney cancer, testicular cancer, prostatic hyperplasia and benign testicular tumor.
He is a member of the Berlin Medical Association, European Association of Urology, Urologic Oncology Association and German Society of Ultrasound in Medicine and Biology.
Dr. Schrader completed his graduation from Johannes Gutenberg University Mainz, Germany and post-graduation from Charité - Universitätsmedizin Berlin, Germany.
He has presented more than 120 research papers.
He has many publications under his name in journals of international repute.

Dr. Ulrih Bitz

Medical Oncologist

Berlin, Germany

15+ years of experience

Chief

Works At: Helios Hospital, Berlin

WhatsApp Us

Dr. Ulrih Bitz is a medical oncologist with 11+ years of experience.
His areas of expertise include Sarcoma, Leiomyosarcoma, Osteosarcoma, Ewing's sarcoma, Rhabdomyosarcoma and Chondrosarcoma.
He completed graduation from Ulm University, Germany.
Dr. Bitz completed training in oncology under the world-renowned.
He is an author of 3 scientific publications.
In 2009, he has conducted clinical studies of new therapies in hematology and oncology.

Dr. Ulrih Bitz is a medical oncologist with 11+ years of experience.
His areas of expertise include Sarcoma, Leiomyosarcoma, Osteosarcoma, Ewing's sarcoma, Rhabdomyosarcoma and Chondrosarcoma.
He completed graduation from Ulm University, Germany.
Dr. Bitz completed training in oncology under the world-renowned.
He is an author of 3 scientific publications.
In 2009, he has conducted clinical studies of new therapies in hematology and oncology.

Dr. Jorg Groticke

Medical Oncologist

Bremen, Germany

29+ years of experience

Chief

Works At: Bremen Ost Clinic, Bremen

WhatsApp Us

Dr. Jorg Groticke is a Clinical Oncologist with 25 years of experience as an expert treating hematological malignancies and gastrointestinal tract tumours.
Dr.Groticke is a Member of the German Cancer Society, Bremen Cancer Society, German Society of Hematology and Medical Oncology and German Network for Evidence-based Medicine.
In 1987, Professor Groticke completed his specialisation in immunology.
His association with the hospital dates back to 1993, when he was awarded the doctor's degree at the hospital's Internal Medicine Department.
His areas of interest include, chemotherapy, immunotherapy, targeted therapy, immunotherapy with keytruda (pembolizumab), chemotherapy for breast cancer and leukemia chemotherapy.

Dr. Jorg Groticke is a Clinical Oncologist with 25 years of experience as an expert treating hematological malignancies and gastrointestinal tract tumours.
Dr.Groticke is a Member of the German Cancer Society, Bremen Cancer Society, German Society of Hematology and Medical Oncology and German Network for Evidence-based Medicine.
In 1987, Professor Groticke completed his specialisation in immunology.
His association with the hospital dates back to 1993, when he was awarded the doctor's degree at the hospital's Internal Medicine Department.
His areas of interest include, chemotherapy, immunotherapy, targeted therapy, immunotherapy with keytruda (pembolizumab), chemotherapy for breast cancer and leukemia chemotherapy.

Prof. Dr. Christian Witt

Medical Oncologist

Berlin, Germany

40+ years of experience

Senior Consultant

Works At: Meoclinic Hospital, Berlin

WhatsApp Us

Prof. Dr. Christian Witt is a well-experienced Medical Oncologist with more than 36 years in the field.
He is a Member of the transplant commission for thoracic organs of the German Heart Center Berlin, German Review Board at Eurotransplant (Leiden, NL), and "Pneumatological Oncology" task force of the German Society for Pneumology and Respiratory Medicine.
He has also been an eminent Pneumatological expert of the examination and monitoring commission of the standing commission for organ transplantation (StäKo) of the German Medical Association (BÄK) and Board member of the Working Group on Pneumatological Oncology (POA) of the German Cancer Society.
He completed studying dentistry at the Ernst-Moritz-Arndt University of Greifswald in 1974 and later studied human medicine from the same institution in 1980.
For further training to become a specialist in internal medicine, he studied at the Polyclinic for Internal Medicine of the Medical Faculty (Charité) of the Humboldt, the University of Berlin in 1984.
Commissioned by the President of the European Parliament as an International Medical Consultant, he holds expertise in managing and treating cancers related to the Lung, Pleura, Esophagus, Stomach, Liver, Gall Bladder, Brain Tumors, Kidney, Prostate, etc.
He has showcased papers at many national conferences and has published notable articles in peer-reviewed journals.

Prof. Dr. Christian Witt is a well-experienced Medical Oncologist with more than 36 years in the field.
He is a Member of the transplant commission for thoracic organs of the German Heart Center Berlin, German Review Board at Eurotransplant (Leiden, NL), and "Pneumatological Oncology" task force of the German Society for Pneumology and Respiratory Medicine.
He has also been an eminent Pneumatological expert of the examination and monitoring commission of the standing commission for organ transplantation (StäKo) of the German Medical Association (BÄK) and Board member of the Working Group on Pneumatological Oncology (POA) of the German Cancer Society.
He completed studying dentistry at the Ernst-Moritz-Arndt University of Greifswald in 1974 and later studied human medicine from the same institution in 1980.
For further training to become a specialist in internal medicine, he studied at the Polyclinic for Internal Medicine of the Medical Faculty (Charité) of the Humboldt, the University of Berlin in 1984.
Commissioned by the President of the European Parliament as an International Medical Consultant, he holds expertise in managing and treating cancers related to the Lung, Pleura, Esophagus, Stomach, Liver, Gall Bladder, Brain Tumors, Kidney, Prostate, etc.
He has showcased papers at many national conferences and has published notable articles in peer-reviewed journals.

Prof. Dr. Ulrich Keilholz

Medical Oncologist

Berlin, Germany

31+ years of experience

Director

Works At: Charite University Hospital

WhatsApp Us

Prof. Dr. Ulrich Keilholz is a Berlin-based Medical Oncologist with more than 27 years in the field.
He is a Member of the American Society for Clinical Oncology (ASCO), the Deutsche Gesellschaft für Hematology/Oncology (DGHO), Arbeitsgemeinschaft Internistische Oncology (AIO). He was the Vice President (2002-2004) and President (2004-2006) of the International Society for Biological Therapy of Cancer (iSBTc).
He is also on the ESMO Faculty (Principles of Clinical Trials and Systemic Therapy, Melanoma, Tumour Immunology & Immunotherapy), and Annals of Oncology Editorial Board member (2011-2014).
He completed studying medicine at the Universities of Mainz, Heidelberg, Lexington, KY, the USA in 1977, and later pursued a doctoral degree at the Institute of Pathophysiology and Sports Medicine, University of Heidelberg/Germany in 1984.
Prof. Keilholz has a wide experience with investigational therapies and has published in several scientific journals such as Lancet, J Clin Oncology, Blood, Leukemia, Cancer Research, Clinical Cancer Research, etc.
He has been actively involved in nearly 20 clinical phase I, II, and III trials covering diseases in medical oncology and haematology, with focus on sarcoma, melanoma, lymphomas, carcinomas of the stomach, ovary, lung, colon, and kidney.

Prof. Dr. Ulrich Keilholz is a Berlin-based Medical Oncologist with more than 27 years in the field.
He is a Member of the American Society for Clinical Oncology (ASCO), the Deutsche Gesellschaft für Hematology/Oncology (DGHO), Arbeitsgemeinschaft Internistische Oncology (AIO). He was the Vice President (2002-2004) and President (2004-2006) of the International Society for Biological Therapy of Cancer (iSBTc).
He is also on the ESMO Faculty (Principles of Clinical Trials and Systemic Therapy, Melanoma, Tumour Immunology & Immunotherapy), and Annals of Oncology Editorial Board member (2011-2014).
He completed studying medicine at the Universities of Mainz, Heidelberg, Lexington, KY, the USA in 1977, and later pursued a doctoral degree at the Institute of Pathophysiology and Sports Medicine, University of Heidelberg/Germany in 1984.
Prof. Keilholz has a wide experience with investigational therapies and has published in several scientific journals such as Lancet, J Clin Oncology, Blood, Leukemia, Cancer Research, Clinical Cancer Research, etc.
He has been actively involved in nearly 20 clinical phase I, II, and III trials covering diseases in medical oncology and haematology, with focus on sarcoma, melanoma, lymphomas, carcinomas of the stomach, ovary, lung, colon, and kidney.

Prof. Dirk Jager

Medical Oncologist

Heidelberg, Germany

32+ years of experience

Chairman

Works At: University Hospital Heidelberg

WhatsApp Us

Prof. Dirk Jager is a well-known Medical Oncologist with more than 28 years in the field.
He is a member of the Cancer Vaccine Collaborative, Cancer Research Institutes, New York, and many such organizations globally.
He studied medicine in Lübeck and Freiburg from 1985 to 1991 and later completed his practical year at the Karlsruhe Municipal Hospital.
In 1998, he successfully completed his specialist examination for internal medicine and then received a two-year research fellowship at the Cancer Research Institute in New York City.
In 2003, he completed his habilitation in internal medicine at the Mainz University Clinic and received recognition for the specialization in hematology and internal oncology in the same year.
He holds expertise in Lymphomas, Bone marrow transplant, Acute Leukemia, Multiple myeloma, Breast Cancer, et al.
He has several publications to his credit in various prestigious national and international journals.

Prof. Dirk Jager is a well-known Medical Oncologist with more than 28 years in the field.
He is a member of the Cancer Vaccine Collaborative, Cancer Research Institutes, New York, and many such organizations globally.
He studied medicine in Lübeck and Freiburg from 1985 to 1991 and later completed his practical year at the Karlsruhe Municipal Hospital.
In 1998, he successfully completed his specialist examination for internal medicine and then received a two-year research fellowship at the Cancer Research Institute in New York City.
In 2003, he completed his habilitation in internal medicine at the Mainz University Clinic and received recognition for the specialization in hematology and internal oncology in the same year.
He holds expertise in Lymphomas, Bone marrow transplant, Acute Leukemia, Multiple myeloma, Breast Cancer, et al.
He has several publications to his credit in various prestigious national and international journals.

Dr. Stefan Schonland

Medical Oncologist

Heidelberg, Germany

28+ years of experience

Senior Consultant

Works At: University Hospital Heidelberg

WhatsApp Us

Dr. Stefan Schonland is a Medical Oncologist with more than 24 years in the field.
He is a Member of the Working Group for Amyloidosis Diseases Heidelberg and the Task Force Leader Amyloidosis of the Medical Clinic V.
He completed studying at the University of Würzburg, Germany in 1990, an Internship at the Dept. of Hematology, Oncology, and Rheumatology at the Ruprecht-Karls-University Heidelberg, and also did a Research Fellowship at the Dept. of Rheumatology, Mayo Clinic, Rochester, MN, USA.
He holds expertise in managing and treating cancers related to the Lung, Pleura, Esophagus, Stomach, Liver, Gall Bladder, Brain Tumors, Kidney, Prostate, etc.
He has written articles and papers for many peer-reviewed journals.

Dr. Stefan Schonland is a Medical Oncologist with more than 24 years in the field.
He is a Member of the Working Group for Amyloidosis Diseases Heidelberg and the Task Force Leader Amyloidosis of the Medical Clinic V.
He completed studying at the University of Würzburg, Germany in 1990, an Internship at the Dept. of Hematology, Oncology, and Rheumatology at the Ruprecht-Karls-University Heidelberg, and also did a Research Fellowship at the Dept. of Rheumatology, Mayo Clinic, Rochester, MN, USA.
He holds expertise in managing and treating cancers related to the Lung, Pleura, Esophagus, Stomach, Liver, Gall Bladder, Brain Tumors, Kidney, Prostate, etc.
He has written articles and papers for many peer-reviewed journals.

Prof. Dr. Med. Michael Von Bergwelt

Medical Oncologist

Munich, Germany

16+ years of experience

Head of Department

Works At: Ludwig Maximilian University Hospital, Munich

WhatsApp Us

Prof. Dr. Med. Michael Von Bergwelt is a highly qualified Oncologist with an experience of 12 years in offering treatment for tumours and sarcomas.
He is a professional member of the German Cancer Consortium (DKTK).
During 1988-96, he completed his medicine from the universities of Muenster, Freiburg and Paris. During this time, he also completed his study of Human Biology from the University of Paris-South XI. Soon after he obtained his Master's degree in Biological and Medical Sciences. In 1997, he submitted his thesis for MD.
He is an expert at treating tumours of the gastrointestinal tract, reproductive system of males and females and breast, malignant ascites, lung cancer, malignant diseases of the gallbladder, pancreas and liver, mesothelioma, head and neck tumours, soft tissue and bone sarcomas.
He has contributed research papers to several publications that have many citations.

Prof. Dr. Med. Michael Von Bergwelt is a highly qualified Oncologist with an experience of 12 years in offering treatment for tumours and sarcomas.
He is a professional member of the German Cancer Consortium (DKTK).
During 1988-96, he completed his medicine from the universities of Muenster, Freiburg and Paris. During this time, he also completed his study of Human Biology from the University of Paris-South XI. Soon after he obtained his Master's degree in Biological and Medical Sciences. In 1997, he submitted his thesis for MD.
He is an expert at treating tumours of the gastrointestinal tract, reproductive system of males and females and breast, malignant ascites, lung cancer, malignant diseases of the gallbladder, pancreas and liver, mesothelioma, head and neck tumours, soft tissue and bone sarcomas.
He has contributed research papers to several publications that have many citations.